In conclusion, circ_0026344 inhibited GC cell proliferation via the miR-1290/FBP2 axis, which might provide a new therapeutic target for GC patients.
Hsa_circ_0026344 suppresses gastric cancer progression via modulating the miR-1290/FBP2 axis.